Diagnostic value of CEA, CYFRA 21-1, NSE and CA 125 assay in serum and pleural effusion of patients with lung cancer.
Wu
Guang-Ping
GP
Ba
Jing
J
Zhao
Yu-Jie
YJ
Wang
En-Hua
EH
D000951:Antigens, Neoplasm / Q000032:analysis* / Q000097:blood; D001681:Biological Assay; D014408:Biomarkers, Tumor / Q000032:analysis / Q000097:blood*; D001774:Blood Chemical Analysis; D018394:CA-125 Antigen / Q000032:analysis* / Q000097:blood; D002272:Carcinoembryonic Antigen / Q000032:analysis* / Q000097:blood; D006801:Humans; D053539:Keratin-19; D007633:Keratins / Q000032:analysis* / Q000097:blood; D008175:Lung Neoplasms / Q000097:blood / Q000201:enzymology / Q000378:metabolism*; D010751:Phosphopyruvate Hydratase / Q000032:analysis* / Q000097:blood; D010996:Pleural Effusion / Q000209:etiology / Q000378:metabolism*; D012680:Sensitivity and Specificity
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D018394:CA-125 Antigen; D002272:Carcinoembryonic Antigen; D053539:Keratin-19; C102012:antigen CYFRA21.1; D007633:Keratins; D010751:Phosphopyruvate Hydratase